BioXcel Therapeutics
BTAI
#9631
Rank
NZ$37.27 M
Marketcap
$0.87
Share price
-10.80%
Change (1 day)
-86.29%
Change (1 year)

BioXcel Therapeutics (BTAI) - Cash on Hand

Cash on Hand as of June 2024 : NZ$96.39 Million

According to BioXcel Therapeutics's latest financial reports the company has NZ$96.39 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

BioXcel Therapeutics - Cash on Hand chart (from 2017 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31NZ$0.30 B-10.54%
2021-12-31NZ$0.34 B15.47%
2020-12-31NZ$0.29 B513.47%
2019-12-31NZ$48.14 M-24.13%
2018-12-31NZ$63.45 M4980.85%
2017-12-31NZ$1.24 M
2016-12-31N/A

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$0.49 B 408.98%๐Ÿ‡บ๐Ÿ‡ธ USA